British Pharmacological Society

British Pharmacological Society
Name	British Pharmacological Society
Formation	1931
Headquarters	London, United Kingdom

British Pharmacological Society. Founded in 1931, it is a leading international learned society dedicated to advancing pharmacology and promoting the safe and effective use of medicines. Its membership includes pharmacologists, clinicians, and scientists from academia, the National Health Service, and the pharmaceutical industry worldwide. The society plays a pivotal role in shaping public policy, supporting education, and disseminating cutting-edge research through its prestigious journals and scientific meetings.

History

The society was established following a pivotal meeting at the University of Oxford, with its inaugural gathering held at the University of Edinburgh. Early influential figures included Sir Henry Hallett Dale, a Nobel laureate renowned for his work on chemical neurotransmission, and Professor J.H. Burn, a foundational thinker in autonomic pharmacology. A significant early achievement was the founding of the British Journal of Pharmacology in 1946, which rapidly became a cornerstone publication in the field. Throughout the 20th century, it expanded its influence, notably through collaborations with the Medical Research Council and engagement with regulatory bodies like the Medicines and Healthcare products Regulatory Agency. Its history is marked by fostering groundbreaking research, from the development of early beta blockers to contemporary biologics and personalised medicine.

Activities and publications

Its core activities centre on organising major scientific conferences, including the annual Pharmacology conference, and specialised symposia on topics like neuropharmacology and cardiovascular pharmacology. It publishes several high-impact journals, most notably the British Journal of Pharmacology and the British Journal of Clinical Pharmacology, which are essential reading for researchers and clinicians. The society is deeply committed to education, providing resources for teaching pharmacology in medical schools and universities, and runs the innovative Pharmacology Matters magazine. It also actively engages in public engagement initiatives and provides expert advice to government committees, including the Committee on Safety of Medicines, influencing drug safety policy and research funding priorities.

Governance and structure

Governance is overseen by an elected Council, led by a President who serves a defined term. The operational work is managed by a professional executive team based in its London office. Scientific and strategic direction is guided by several specialized committees, such as those focused on clinical pharmacology, safety pharmacology, and education. Membership is organised into various categories, including Full Member, Associate Member, and Fellow, with specific pathways for early-career scientists through its Early Career Pharmacologists network. The society maintains a close working relationship with its affiliated charity, the British Pharmacological Society (Charity), which supports its educational and grant-giving missions.

Awards and prizes

It bestows a range of prestigious awards to recognise excellence. The highest honour is the Gaddum Memorial Lecture, named after Sir John Henry Gaddum. Other major prizes include the Sandoz Prize for basic pharmacology, the Dale Medal for clinical pharmacology, and the A.J. Clark Award for early-career researchers. The society also offers numerous travel grants and studentships, such as those funded by the Wellcome Trust, to support attendance at international meetings like the World Congress of Pharmacology. These awards celebrate contributions from luminaries such as Professor Humphrey Rang and Sir James Black, the Nobel Prize-winning developer of propranolol.

Affiliations and partnerships

The society maintains formal affiliations with numerous international bodies, including the International Union of Basic and Clinical Pharmacology (IUPHAR) and the European Association for Clinical Pharmacology and Therapeutics. It is a founding partner of the Pharmacology Futures project and collaborates closely with the Academy of Medical Sciences and the Royal Society of Chemistry. Within the UK, it works with the Association of the British Pharmaceutical Industry, the BioIndustry Association, and research funders like the Medical Research Council and National Institute for Health and Care Research. These partnerships are crucial for global initiatives in drug discovery, regulatory science, and harmonising pharmacology education standards.

Notable members

Throughout its history, its membership has included many of the world's most influential pharmacologists. Founding members and early leaders included Nobel laureates Sir Henry Hallett Dale and Sir John Vane, discoverer of the mechanism of action of aspirin. Other distinguished Fellows have included Professor Annmarie Surprenant, a leading figure in neuronal signalling, and Sir Michael Rawlins, former chairman of NICE. Contemporary influential members feature experts like Professor David Webb, a key contributor to vascular pharmacology, and Professor Michele Evans, who has advanced research in receptor pharmacology. Their collective work, often published in journals like Nature and Science, has fundamentally shaped modern therapeutics.

Category:Pharmacology organizations Category:Medical and health organisations based in the United Kingdom Category:Scientific organizations established in 1931